azacitidine has been researched along with Germinoblastoma in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (35.00) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 11 (27.50) | 29.6817 |
| 2010's | 11 (27.50) | 24.3611 |
| 2020's | 2 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciernikova, S; Fridrichova, I; Kalinkova, L; Sevcikova, A; Stevurkova, V | 1 |
| Horwitz, SM; Weinstock, DM | 1 |
| Chen, J; Dean, R; Dever, M; Fada, S; Hill, B; Jagadeesh, D; Lindner, D; Morrison, A; Parameswaran, N; Pohlman, B; Radivoyevitch, T; Robinson, S; Saunthararajah, Y; Smith, M | 1 |
| Aoyagi, T; Daitoku, S; Kuroiwa, M; Tada, S; Takao, S | 1 |
| Richards, KL; Small, GW; Smallwood, TL; Suter, SE | 1 |
| Fujino, Y; Fujiwara-Igarashi, A; Goto-Koshino, Y; Mochizuki, H; Ohno, K; Sato, M; Tsujimoto, H | 1 |
| Chen, M; Fan, H; Feng, K; Fu, X; Guo, B; Han, W; Liu, Y; Lu, X; Nie, J; Shi, F; Wang, X; Wang, Y; Zhang, W; Zhang, Y; Zhu, H | 1 |
| Ahmed, S; Alousi, A; Anderlini, P; Andersson, BS; Bashir, Q; Champlin, R; Dabaja, B; Fanale, M; Gulbis, A; Hosing, C; Jones, RB; Myers, A; Nieto, Y; Oki, Y; Pinnix, C; Popat, U; Qazilbash, M; Shah, N; Shpall, EJ; Thall, PF; Valdez, BC; Wei, W | 1 |
| Guo, Z; Gupta, S; Hong, D; Issa, JP; Jelinek, J; Kurzrock, R; Nunez, MI; Oki, Y; Stewart, DJ; Wistuba, II | 1 |
| Gao, L; Kang, H; Li, Y; Wang, L; Wang, W; Wang, X; Yu, L | 1 |
| Chim, CS; Chung, LP; Jin, DY; Lam, WW; Li, GK; Liang, R; Loong, F; So, CC; Wong, KY | 1 |
| Cui, XY; Gao, WF; Lin, YM; Ma, XT; Wang, N; Yang, BX; Yao, XR | 1 |
| Andersson, BS; Champlin, RE; Li, Y; Murray, D; Nieto, Y; Valdez, BC; Wang, G | 1 |
| Bondada, S; Brandon, J; Bryson, JS; Howard, D; Liang, Y; Liu, Y; Mehta, J; Rector, K; Schook, L; Swiderski, C | 1 |
| Caron, M; Joubert-Caron, R; Labas, V; Poirier, F | 1 |
| Drach, J; Feng, Z; Gazdar, AF; Kroft, SH; McKenna, RW; Miyajima, K; Parikh, G; Reddy, J; Shigematsu, H; Shivapurkar, N; Suzuki, M; Takahashi, T; Timmons, C; Toyooka, S; Zheng, Y; Zöchbauer-Müller, S | 1 |
| Bernstein, M; Momparler, RL; Shaker, S | 1 |
| Fujimoto, H; Imamura, M; Kato, N; Kondo, T; Matsumura, N; Minami, Y; Oishi, I; Tanaka, Y; Tsukada, J; Yoda, A | 1 |
| Ishii, M; Kamihira, S; Kusunoki, M; Nakatani, K; Nakazawa, K; Nishioka, J; Nobori, T; Wada, H; Yamada, Y | 1 |
| Fang, JC; Feng, ZY; He, D; He, XL; Li, L; Qiu, G; Su, ZL; Zhu, MF | 1 |
| Jagodzinski, PP; Piotrowska, H | 1 |
| Jagodziński, PP; Kozłowska, A | 1 |
| Boyd, AW; Schrader, JW | 1 |
| Asofsky, R; Hirschhorn, R; Kim, J; Ratech, H; Thorbecke, GJ | 1 |
| Anderson, NL; Gemmell, MA | 1 |
| Georgiev, G; Grigorian, M; Lukanidin, E; Tkatch, T; Tulchinsky, E | 1 |
| Odum, N; Raghunath, PN; Vonderheid, E; Wasik, MA; Zhang, Q | 1 |
| Carter, KB; Cauthron, RD; Gan, J; Steinberg, RA; Zhang, YL | 1 |
| Broome, JD; Goodwin, LO; Issa, JP; Koduru, P; Peng, H; Qian, L; Shen, N; Sun, XL | 1 |
| Geber, E; Lehmacher, W; Schmahl, W | 1 |
| Bourgeois, S; Harmon, JM; Smith, JR; Thompson, EB | 1 |
| Altevogt, P | 1 |
| Gunter, KC; Sneller, MC | 1 |
| Borri-Voltattorni, C; Dominici, P; Fioretti, MC; Fuschiotti, P; Puccetti, P; Romani, L | 1 |
| Bufalari, A; Cavaliere, A; Vitali, R | 1 |
| Chan, C; Germain, RN; Gunter, KC; Leo, O; Shevach, EM | 1 |
| Niericker, MJ; Simons, JW; van Zeeland, AA; Vrieling, H | 1 |
| Diamant, M; Due, C; Olsson, L | 1 |
| Glynn, JP; Goldberg, AI; Goldin, A; Kende, M; Mantel, N | 1 |
| Bruntsch, U; Gallmeier, WM; Osieka, R; Schmidt, CG; Seeber, S | 1 |
2 review(s) available for azacitidine and Germinoblastoma
| Article | Year |
|---|---|
Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool.
Topics: Azacitidine; Decitabine; DNA Methylation; Epigenesis, Genetic; Hematologic Neoplasms; Humans; Leukemia; Lymphoma; Myelodysplastic Syndromes; Prognosis | 2022 |
Glucocorticoid receptors in human leukemias and related diseases.
Topics: Animals; Azacitidine; Cell Line; Cell Survival; Clone Cells; Decitabine; Dexamethasone; Drug Resistance; Glucocorticoids; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Mice; Mutation; Phenotype; Prognosis; Receptors, Glucocorticoid | 1985 |
3 trial(s) available for azacitidine and Germinoblastoma
| Article | Year |
|---|---|
A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignancies.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Epigenesis, Genetic; Humans; Lymphoma; Pilot Projects; Tetrahydrouridine | 2021 |
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II report.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Decitabine; DNA Methylation; DNA Modification Methylases; Double-Blind Method; Doxorubicin; Female; Humans; Immunotherapy; Killer Cells, Natural; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Prednisone; Prospective Studies; Survival Analysis; Vincristine | 2014 |
Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Blood Pressure; Cation Transport Proteins; Copper Transporter 1; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Hydrogen-Ion Concentration; In Situ Nick-End Labeling; Ki-67 Antigen; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Neoplasms; Sex Factors; Treatment Outcome; Young Adult | 2009 |
35 other study(ies) available for azacitidine and Germinoblastoma
| Article | Year |
|---|---|
TFH lymphomas: the times they aza-changin'?
Topics: Azacitidine; Depsipeptides; Humans; Lymphoma; T-Lymphocytes, Helper-Inducer | 2019 |
Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Low-risk Myelodysplastic Syndrome by Azacitidine.
Topics: Aged; Antimetabolites, Antineoplastic; Asian People; Azacitidine; Hematologic Neoplasms; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Myelodysplastic Syndromes; Treatment Outcome | 2018 |
Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines.
Topics: Animals; Asparaginase; Aspartate-Ammonia Ligase; Azacitidine; Cell Line, Tumor; Disease Models, Animal; DNA Methylation; Dogs; Drug Resistance, Neoplasm; Gene Expression; Humans; Lymphocytes; Lymphoma; Promoter Regions, Genetic; RNA, Messenger | 2014 |
Inhibition of p16 tumor suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells.
Topics: Animals; Azacitidine; Base Sequence; Cell Line, Tumor; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; DNA Primers; Dog Diseases; Dogs; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Genes, Tumor Suppressor; Lymphoma; Molecular Sequence Data; Promoter Regions, Genetic | 2014 |
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Busulfan; Child; Deoxycytidine; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Follow-Up Studies; Gemcitabine; Humans; Hydroxamic Acids; Lymphoma; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Vorinostat; Young Adult | 2016 |
Modulation of the poliovirus receptor expression in malignant lymphocytes by epigenetic alterations.
Topics: Azacitidine; Cell Line, Tumor; CpG Islands; Cytotoxicity, Immunologic; DNA Methylation; Enzyme Inhibitors; Epigenomics; Gene Expression Regulation; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; K562 Cells; Killer Cells, Natural; Leukemia, Lymphoid; Lymphoma; Receptors, Virus; RNA, Messenger | 2011 |
Epigenetic inactivation of the miR-124-1 in haematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase 6; Epigenesis, Genetic; Female; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylation; MicroRNAs; Middle Aged; Multiple Myeloma; Reverse Transcriptase Polymerase Chain Reaction; Young Adult | 2011 |
HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.
Topics: Azacitidine; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Hematologic Neoplasms; HL-60 Cells; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Molecular Chaperones; Protein Serine-Threonine Kinases; Tumor Cells, Cultured | 2012 |
Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.
Topics: Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; Azacitidine; Busulfan; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Cytotoxins; Decitabine; Deoxycytidine; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Epigenesis, Genetic; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Lymphoma; Melphalan; Protein Serine-Threonine Kinases; Transplantation Conditioning; Transplantation, Homologous; Tumor Suppressor Proteins | 2012 |
Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth.
Topics: Animals; Antigens; Antigens, CD34; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; CpG Islands; DNA Methylation; Down-Regulation; Female; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Indicators and Reagents; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Promoter Regions, Genetic | 2012 |
Proteomic analysis of a lymphoma-derived cell line (DG75) following treatment with a demethylating drug: modification of membrane-associated proteins.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Chromatography, Liquid; Gels; Humans; Lymphoma; Mass Spectrometry; Membrane Proteins; Proteome; Proteomics; Proton-Motive Force; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2003 |
DNA methylation profiles of lymphoid and hematopoietic malignancies.
Topics: Age Factors; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Leukemia; Logistic Models; Lymphoma; Male; Middle Aged; Multiple Myeloma; Promoter Regions, Genetic; Sex Factors | 2004 |
Antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and depsipeptide on Raji lymphoma cells.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cadherins; Cell Division; Chromatin; Colony-Forming Units Assay; Decitabine; Depsipeptides; DNA Methylation; DNA Modification Methylases; Drug Combinations; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylase Inhibitors; Humans; In Vitro Techniques; Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tumor Cells, Cultured | 2004 |
Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines.
Topics: Acetylation; Apoptosis; Azacitidine; Butyrates; Cell Line, Tumor; Checkpoint Kinase 2; Decitabine; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Hodgkin Disease; Humans; Hydroxamic Acids; Lymphoma; Methylation; Protein Serine-Threonine Kinases; RNA, Messenger | 2004 |
Methylthioadenosine phosphorylase gene is silenced by promoter hypermethylation in human lymphoma cell line DHL-9: another mechanism of enzyme deficiency.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Decitabine; DNA Methylation; Gene Silencing; Humans; Lymphoma; Molecular Sequence Data; Polymerase Chain Reaction; Promoter Regions, Genetic; Purine-Nucleoside Phosphorylase; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2005 |
[SHP-1 gene's methylation status of Daudi lymphoma cell and the demethylation effect of 5-aza-2'-deoxycytidine].
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Humans; Lymphoma; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Trichostatin A, sodium butyrate, and 5-aza-2'-deoxycytidine alter the expression of glucocorticoid receptor alpha and beta isoforms in Hut-78 T- and Raji B-lymphoma cell lines.
Topics: Antineoplastic Agents; Azacitidine; Blotting, Western; Butyrates; Cell Line, Tumor; Decitabine; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Lymphoma; Polymerase Chain Reaction; Receptors, Glucocorticoid; Reverse Transcription | 2007 |
Inhibition of DNA methyltransferase activity upregulates Fyn tyrosine kinase expression in Hut-78 T-lymphoma cells.
Topics: Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Humans; Lymphoma; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fyn; Up-Regulation | 2008 |
Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine.
Topics: Animals; Azacitidine; B-Lymphocytes; Butyrates; Cell Differentiation; Cell Line; Lymphoma; Macrophages; Mice | 1982 |
Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Topics: Adenosine Deaminase; Animals; Azacitidine; Body Weight; Coformycin; Deoxyadenosines; DNA; Lymphoma; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Neoplasm Transplantation; Nucleoside Deaminases; Organ Size; Pentostatin; Phenotype; Ribonucleosides; Spleen; T-Lymphocytes; Thymus Gland | 1984 |
Protein-pattern changes and morphological effects due to methionine starvation or treatment with 5-azacytidine of the phorbol-ester-sensitive cell lines HL-60, CCL-119, and U-937.
Topics: Azacitidine; Cell Line; Cell Nucleus; Cytoskeleton; Electrophoresis, Polyacrylamide Gel; Humans; Isoelectric Focusing; Leukemia, Myeloid; Lymphoma; Methionine; Protein Biosynthesis; Proteins; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1984 |
Transcriptional regulation of the mts1 gene in human lymphoma cells: the role of DNA-methylation.
Topics: Azacitidine; Decitabine; DNA Modification Methylases; Gene Expression Regulation; Humans; Lymphoma; Methylation; Neoplasm Metastasis; Restriction Mapping; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
Topics: Azacitidine; Base Sequence; Decitabine; DNA Methylation; DNA Modification Methylases; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 3; Lymphoma; Lymphoma, T-Cell, Cutaneous; Phosphorylation; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured | 2000 |
On the spontaneous mutability of CpG sites in cultured S49 mouse lymphoma cells.
Topics: 5-Methylcytosine; Animals; Arginine; Azacitidine; Cytosine; Dinucleoside Phosphates; DNA Methylation; DNA, Neoplasm; Hypoxanthine Phosphoribosyltransferase; Lymphoma; Mice; Mutagenesis; Tumor Cells, Cultured | 1999 |
Hypermethylation of CpG islands in the mouse asparagine synthetase gene: relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells.
Topics: Animals; Asparaginase; Aspartate-Ammonia Ligase; Azacitidine; Base Sequence; Blotting, Northern; CpG Islands; Decitabine; DNA; DNA Modification Methylases; DNA Primers; Gene Amplification; Liver; Lymphoma; Methylation; Mice; Mice, Inbred C3H; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Nucleic Acid; Spleen; Tumor Cells, Cultured | 2001 |
Diaplacental carcinogenic effects of 5-azacytidine in NMRI-mice.
Topics: Animals; Azacitidine; Fetus; Leukemia, Experimental; Liver Neoplasms, Experimental; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Sarcoma, Experimental; Soft Tissue Neoplasms | 1985 |
Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine.
Topics: Animals; Azacitidine; Cell Line; DNA, Neoplasm; Epitopes; Lymphoma; Membrane Proteins; Methylation; Methylnitronitrosoguanidine; Mice; Mice, Inbred DBA; Mutagens; Neoplasm Transplantation; T-Lymphocytes, Cytotoxic | 1986 |
DNA methylation alters chromatin structure and regulates Thy-1 expression in EL-4 T cells.
Topics: 5-Methylcytosine; Animals; Antigens, Surface; Azacitidine; Cell Line; Chromatin; Cytosine; Decitabine; DNA, Neoplasm; Ethyl Methanesulfonate; Gene Expression Regulation; Lymphoma; Methylation; Mice; Mice, Inbred C57BL; RNA, Messenger; T-Lymphocytes; Thy-1 Antigens | 1987 |
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives.
Topics: Animals; Azacitidine; Carmustine; Cell Line; Cytarabine; Dacarbazine; DNA, Neoplasm; Lymphoma; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Quinacrine; Triazenes | 1987 |
5-Azacytidine carcinogenesis in BALB/c mice.
Topics: Animals; Azacitidine; Carcinogens; Female; Lung Neoplasms; Lymphoma; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Skin Neoplasms | 1987 |
Mitogenic activation of EL-4 cells does not require surface Thy-1 expression.
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Azacitidine; Cell Line; Lymphocyte Activation; Lymphoma; Mice; Mitogens; Mutation; Phenotype; T-Lymphocytes; Thy-1 Antigens; Transfection | 1988 |
Molecular analysis of mutations induced by N-ethyl-N-nitrosourea at the HPRT locus in mouse lymphoma cells.
Topics: Animals; Azacitidine; DNA; Ethylnitrosourea; Hypoxanthine Phosphoribosyltransferase; Lymphoma; Mice; Mutation; Neoplasm Proteins; Tumor Cells, Cultured | 1988 |
Treatment of human cell lines with 5-azacytidine may result in profound alterations in clonogenicity and growth rate.
Topics: Azacitidine; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cells, Cultured; Clone Cells; Humans; Lung Neoplasms; Lymphoma; Multiple Myeloma | 1985 |
A two-stage therapeutic design in the spontaneous AKR lymphoma system.
Topics: Amides; Animals; Antineoplastic Agents; Azacitidine; Cyclic P-Oxides; Cyclophosphamide; Cytarabine; Disease Models, Animal; Drug Combinations; Female; Imidazoles; Lymphoma; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred Strains; Oxazines; Prednisone; Remission, Spontaneous; Time Factors; Triazenes; Vincristine | 1972 |
[New cytostatics in oncological therapy].
Topics: Antineoplastic Agents; Azacitidine; Breast Neoplasms; Chemical Phenomena; Chemistry; DNA Replication; DNA, Neoplasm; Doxorubicin; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Lymphoma; Male; Mitolactol; Neoplasms; Nitrosourea Compounds; Testicular Neoplasms; Thyroid Neoplasms | 1974 |